Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Validation of Clinical Classification Schemes for Predicting Stroke

Brian F. Gage, Amy D. Waterman, William D. Shannon et al. · JAMA · 2001 · 4.8K citations

Medicine, Cardiology, Internal Medicine +17

Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation

Archives of Internal Medicine · 1994 · 2.1K citations

Medicine, Cardiology, Neurology +12

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

DanielL Dries, D. Exner, BernardJ Gersh et al. · Journal of the American College of Cardiology · 1998 · 976 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin

Elaine M. Hylek · Annals of Internal Medicine · 1994 · 923 citations

Medicine, Hematology, Pharmacotherapy +13